PharmaCyte Biotech (PMCB) Long-Term Debt Issuances (2010 - 2022)
PharmaCyte Biotech (PMCB) posted quarterly Long-Term Debt Issuances of $50805.0 for Q2 2022, up 200.0% year-over-year from $16935.0 in Q2 2021, and up 200.0% quarter-over-quarter from -$50805.0 in Q2 2021.
PharmaCyte Biotech (PMCB) Long-Term Debt Issuances (2010 - 2022) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Long-Term Debt Issuances for 7 consecutive years, with $50805.0 the latest figure, recorded in Q2 2022.
- In Q2 2022, Long-Term Debt Issuances rose 200.0% year-over-year to $50805.0; the TTM figure through Apr 2022 stood at $38169.0 (up 402.07% YoY), while the FY2022 annual figure was $50805.0, down 18.63% from the prior year.
- Long-Term Debt Issuances rose to $50805.0 in Q2 2022 per PMCB's latest filing, from -$50805.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $50805.0 in Q2 2022 and bottomed at -$50805.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2022 | 50,805.00 |
| Apr 30, 2022 | 50,805.00 |
| Apr 30, 2021 | -50,805.00 |
| Apr 30, 2021 | -50,805.00 |
| Jan 31, 2021 | 38,169.00 |
| Jan 31, 2021 | 38,169.00 |
| Oct 31, 2014 | 125,142.00 |
| Oct 31, 2014 | 125,142.00 |
| Jul 31, 2014 | 18,717.00 |
| Jul 31, 2014 | 18,717.00 |
| Apr 30, 2014 | 3,717.00 |
| Apr 30, 2014 | 3,717.00 |
| Oct 31, 2013 | 16.00 |
| Oct 31, 2013 | 16.00 |
| Jul 31, 2013 | 77,853.00 |
| Jul 31, 2013 | 77,853.00 |
| Apr 30, 2013 | 88,245.00 |
| Apr 30, 2013 | 88,245.00 |
| Jan 31, 2013 | 6,408.00 |
| Jan 31, 2013 | 6,408.00 |